Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment

The present study aimed to assess the suppressive effect of direct-acting antivirals (DAAs) on hepatocellular carcinoma (HCC) recurrence following curative treatment, particularly compared with interferon (IFN)-based therapy. Among 117 curative cases of HCV-related initial HCC between 2006 and 2017...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Clin Oncol
Päätekijät: Imai, Kenji, Takai, Koji, Hanai, Tatsunori, Suetsugu, Atsushi, Shiraki, Makoto, Shimizu, Masahito
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2020
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6951252/
https://ncbi.nlm.nih.gov/pubmed/31929880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1956
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia